ArticleIndian journal of surgical oncology2025
Development of a Logistic Regression Model for Colorectal Cancer Relapse Prediction in Sabah, Malaysia.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) remains one of the leading causes of cancer-related deaths in Malaysia, with relapse contributing substantially to poor survival outcomes. Despite advances in treatment, relapse surveillance continues to rely on non-individualized schedules. This study aimed to develop and internally validate an interpretable logistic regression model for predicting relapse among Malaysian CRC survivors using routinely available clinical and pathological variables. A retrospective case-control study was conducted using data from hospital-based cancer registries and oncology records across selected public hospitals in Sabah. Patients diagnosed between 2015 and 2020 who completed curative-intent treatment with at least five years of follow-up were included. Ten routinely collected clinicopathological variables were evaluated as candidate predictors using multivariable logistic regression. Model performance was assessed with 10-fold cross-validation. Discrimination was measured using the area under the receiver operating characteristic curve (AUC), and calibration was assessed across risk strata. The optimal probability threshold was identified using the Youden index. Six predictors remained significant in the final model, including tumor stage, lymphovascular and perineural invasion, carcinoembryonic antigen level, tumor grade, and completeness of chemotherapy (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.